Research Article
IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment
Table 6
Association of the level of anti-GlcNAcβ Abs with portal inflammation score.
|